Eileen Appelbaum is Co-Director of the Center for Economic and Policy Research, Washington, DC, Fellow at Rutgers University Center for Women and Work, and Visiting Professor at the University of Leicester, UK. Prior to joining CEPR, she held positions as Distinguished Professor and Director of the Center for Women and Work at Rutgers University and as Professor of Economics at Temple University.  She holds a PhD in economics from the University of Pennsylvania.

Dr. Appelbaum’s research focuses on organizational restructuring and outcomes for firms and workers; private equity and financialization; and work-family policies. Private Equity at Work: When Wall Street Manages Main Street, coauthored with Rosemary Batt, was selected by the Academy of Management as one of the four best books of 2014 and 2015, and was a finalist for the 2016 George R. Terry award. Unfinished Business, coauthored with Ruth Milkman, examines the effects of paid family leave in California on employers and employees. It has been widely cited in discussions of national paid family and medical leave policy. Her current research examines the implications of consolidation of hospitals and decentralization of health services to outpatient care centers for the jobs of non-professional employees in these two segments of the healthcare industry.

Several of Dr. Appelbaum’s earlier books – The New American Workplace with Rosemary Batt, Low Wage America with Annette Bernhardt and Richard Murnane, and Manufacturing Advantage with Peter Berg, Thomas Bailey and Arne Kalleberg – were selected by Princeton University for its distinguished list of Noteworthy Books in Industrial Relations and Labor Economics.

She has published numerous articles in peer-reviewed journals, including “Domestic Outsourcing, Rent Seeking, and Increasing Inequality,” RRPE, 2017: 1-16 and “Implications of Financial Capitalism for Employment Relations Research: Evidence from Breach of Trust and Implicit Contracts in Private Equity Buyouts,” British Journal of Industrial Relations 51(3): 498–518, 2013.

By this expert

Private Equity Buyouts in Healthcare: Who Wins, Who Loses?

Article | Mar 25, 2020

As we face a coronavirus-induced health and economic crisis of uncertain duration, policy makers should be particularly concerned about private equity’s heightened use of debt to buy out healthcare providers and take them private, with no regulatory oversight.

Private Equity Buyouts in Healthcare: Who Wins, Who Loses?

Paper Working Paper Series | | Mar 2020

Private equity firms have become major players in the healthcare industry. How has this happened and what are the results?

Private Equity and Surprise Medical Billing

Article | Sep 4, 2019

How Investor-owned Physician Practices Are Driving up Healthcare Costs

Featuring this expert

Appelbaum & Batt’s INET funded research is cited in the Boston Globe

News Apr 5, 2021

“In “Private Equity’s Engagement With Health Care: Cause for Concern?” a report to the Institute for New Economic Thinking, researchers Eileen Applebaum and Rosemary Batt found that wages dropped at urgent care centers after acquisitions by private equity companies. They were 9 to 12 percent lower than hospital wages. More consolidation and Amazon’s relentless drive to suppress costs bode more of the same.” — Brian Alexander, Boston Globe

Appelbaum and Batt’s research into Private Equity buyouts is cited in Emergency Medical News

News Jan 5, 2021

“The landscape of EM has consolidated into a few corporate conglomerates, which are oligarchies with iron grips on contracts through noncompetitive or illegal collusions with large hospital systems in the form of kickbacks. (Institute for New Economic Thinking. March 15, 2020; https://bit.ly/34fLeMD.) This has effectively castrated any hope for independent practices to thrive and injected many wrongful consequences into EM.” — Rizvi, Saba MD, Emergency Medical News

INET research by Appelbaum and Batt on private equity and healthcare was cited in ACP Hospitalist

News Dec 15, 2020

Private equity’s stake in health care increased rapidly in recent years, reaching a record of 855 deals valued at $100 billion in 2018, according to a March 2020 study published by the Institute for New Economic Thinking, a nonprofit think tank based in New York City. — Janet Colwell, ACP Hospitalist

The Hidden Costs of Healthcare

Video | Nov 20, 2019

INET experts discuss how financialization has driven up costs of healthcare—and how we can stop it.